Phase 3 Readout
AAPG: Phase 3 Topline: A Global Multicenter Open Label Randomized Phase III Confirmatory Study of Lisaftoclax (APG-2575) in
August 1, 2028 · lisaftoclax. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 1, 2028
- Company
- ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Drug
- lisaftoclax
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Global Multicenter Open Label Randomized Phase III Confirmatory Study of Lisaftoclax (APG-2575) in
- Drug
- lisaftoclax
- Indication
- CLL/SLL